{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1213.109",
  "meta" : {
    "versionId" : "9",
    "lastUpdated" : "2023-12-15T19:18:20.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Meaningful Drug Interaction Alerts Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-12-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-12-15"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1213.109"
    }
  ],
  "version" : "20231215",
  "name" : "OralAnticoagulantIngredientsAndRiskOfGIBleeding",
  "title" : "Oral Anticoagulant Ingredients and Risk of GI Bleeding",
  "status" : "active",
  "date" : "2023-12-15T19:18:20-05:00",
  "publisher" : "Meaningful Drug Interaction Alerts Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for oral anticoagulants at an ingredietn level and identified products containing those: warfarin, apixaban, edoxaban, dabigatran and rivaroxaban),(Data Element Scope: This value uses the corresponding RxCui for each ingredient of interest),(Inclusion Criteria: Includes concepts that describe oral anticoagulants),(Exclusion Criteria: Excludes concepts that describe branded and non-prescribable oral anticoagulants)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1037042",
            "display" : "dabigatran etexilate"
          },
          {
            "code" : "1114195",
            "display" : "rivaroxaban"
          },
          {
            "code" : "11289",
            "display" : "warfarin"
          },
          {
            "code" : "1364430",
            "display" : "apixaban"
          },
          {
            "code" : "1546356",
            "display" : "dabigatran"
          },
          {
            "code" : "1599538",
            "display" : "edoxaban"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:6c3a8f19-2684-4db4-afd7-397b6d935697",
    "timestamp" : "2024-06-14T13:36:11-04:00",
    "total" : 6,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1037042",
        "display" : "dabigatran etexilate"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1114195",
        "display" : "rivaroxaban"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "11289",
        "display" : "warfarin"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1364430",
        "display" : "apixaban"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1546356",
        "display" : "dabigatran"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1599538",
        "display" : "edoxaban"
      }
    ]
  }
}
